Authors : Z. N. Kashmiri and S. A. Mankar
Page Nos : 424-432
Description :
Cancer is one of the leading causes of death all over the world. Every year millions of death occurs due to this malignant disease. Therefore early diagnosis and prevention are key factors needed to reduce the mortality and morbidity of all types of cancer. But, currently available cancer screening tools such as mammography and invasive needle or surgical evaluation for breast cancer; or chest X-ray for lung cancer, etc. are not sensitive enough for early detection of the disease. It is essential to develop non invasive techniques that differentiate between patients with and without cancer, as well as between stages of cancer. Recently, significant progress has been made in the development of new proteomics technology. The progress that has been made in this field is helpful in identifying biomarkers that can be used for early diagnosis of cancer and improving the understanding of the molecular etiological mechanism of cancer. This article focuses on the present status of proteomics in this field.
